Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
Flash
12:46
Pieverse launches on-chain agent infrastructure Purr-Fect Claw, enabling BNB Chain ecosystem integration with mainstream social applications
Foresight News reports that Pieverse has launched the on-chain OpenClaw infrastructure, Purr-Fect Claw, which supports integrating the BNB Chain ecosystem into social applications such as Line, Kakao, and WhatsApp. The platform allows projects within the BNB Chain ecosystem to deploy autonomous AI agents in users' commonly used instant messaging apps, providing one-click setup and production-grade infrastructure. The core features of Purr-Fect Claw include: a keyless agent wallet based on TEE (Trusted Execution Environment), ensuring that keys are not leaked during operation; support for directly executing contract calls, DEX swaps, and portfolio rebalancing through chat windows in social apps; token-bound agent authorization based on ERC-6551, allowing agents to operate users' existing wallets within set limits and timeframes; and binding ERC-8004 agent identities to real-time runtime environments, enabling AI agents to have verifiable and transferable on-chain identities.
12:24
ROMAN DBDR ACQUISITION CORP II recently disclosed that, through a price-based earnout mechanism, the company’s transaction value is expected to achieve significant growth.
Specifically, if the company's stock price reaches the preset target, the transaction value may increase by an additional $450 million, bringing the total value up to a maximum of $1.3 billion. This profit target mechanism is designed to incentivize the company's management to improve performance and drive the stock price higher. As market expectations for the company's future development heat up, investors are closely monitoring its stock price performance and the potential for value realization.
12:24
TransMedics Group (TMDX) recently provided additional disclosure regarding the specific impact of the release of the deferred tax asset valuation allowance in relation to its previously announced fourth-quarter financial results.
The company stated that the release of this valuation allowance resulted in a significant adjustment to the carrying value of its deferred income tax assets, thereby having a substantial impact on the relevant items in the fourth quarter financial statements. TransMedics emphasized that this adjustment will not have a direct impact on the company's cash flow or business operations, but it will help more accurately reflect the actual value of its tax assets.
News